But serum albumin level was significantly lower in the MPR group than in the non-MPR group (39.7 ± 4.4 vs. 43.2 ± 3.3 g/L, P = 0.024), which may be attributed to multiple factors such as hepatic function and tumor-related metabolic consumption (Figure 5A). The gene discussed is ALB; the disease is neoplasm.